Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis
- PMID: 20488751
- DOI: 10.1016/j.pt.2010.04.005
Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis
Abstract
The control of infection by Leishmania infantum (syn. Leishmania chagasi) in dogs is essential to stop the current spread of zoonotic visceral leishmaniasis. The past few years have seen significant advances in achieving efficient immunization of dogs and, more than ever before, an effective vaccine against canine leishmaniasis can now be considered a feasible goal. This article summarizes experimental data gathered from recent dog trials aimed at identifying immunological mechanisms implicated in protection against canine infection to discuss their potential to serve as quantitative surrogate markers of immunization and, more importantly, its usefulness to evaluate whether the immunity induced by the vaccine candidate is strong enough to protect against canine leishmaniasis.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15. Vaccine. 2007. PMID: 17395339 Clinical Trial.
-
Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.Vaccine. 2008 Jan 17;26(3):333-44. doi: 10.1016/j.vaccine.2007.11.021. Epub 2007 Nov 29. Vaccine. 2008. PMID: 18093705
-
Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis.Res Vet Sci. 2008 Aug;85(1):106-12. doi: 10.1016/j.rvsc.2007.09.008. Epub 2007 Oct 22. Res Vet Sci. 2008. PMID: 17950391 Clinical Trial.
-
Immunology of canine leishmaniasis.Parasite Immunol. 2006 Jul;28(7):329-37. doi: 10.1111/j.1365-3024.2006.00840.x. Parasite Immunol. 2006. PMID: 16842269 Review.
-
Cytokine profiles in canine visceral leishmaniasis.Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):67-70. doi: 10.1016/j.vetimm.2008.10.310. Epub 2008 Oct 17. Vet Immunol Immunopathol. 2009. PMID: 19054573 Review.
Cited by
-
Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice.Vaccines (Basel). 2019 Oct 28;7(4):162. doi: 10.3390/vaccines7040162. Vaccines (Basel). 2019. PMID: 31661776 Free PMC article.
-
Characterization of the early inflammatory infiltrate at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites.PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2781. doi: 10.1371/journal.pntd.0002781. eCollection 2014 Apr. PLoS Negl Trop Dis. 2014. PMID: 24762408 Free PMC article.
-
Setting the proportion of CD4+ and CD8+ T-cells co-cultured with canine macrophages infected with Leishmania chagasi.Vet Parasitol. 2015 Jul 30;211(3-4):124-32. doi: 10.1016/j.vetpar.2015.05.025. Epub 2015 Jun 3. Vet Parasitol. 2015. PMID: 26095951 Free PMC article.
-
Editorial: Biomarkers in Leishmaniasis.Front Cell Infect Microbiol. 2019 Nov 12;9:388. doi: 10.3389/fcimb.2019.00388. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31781519 Free PMC article. No abstract available.
-
Investigation of canine visceral leishmaniasis in a non-endemic area in Brazil and the comparison of serological and molecular diagnostic tests.Rev Soc Bras Med Trop. 2021 Sep 6;54:e01822021. doi: 10.1590/0037-8682-0182-2021. eCollection 2021. Rev Soc Bras Med Trop. 2021. PMID: 34495256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous